Page 485 - 16Neonatal Jaundice_compressed
P. 485

Appendix H: Evidence tables


 Bibliographic   Study Type &   Number of   Intervention & Comparison   Dichotomous outcomes   Continuous Outcomes   Comments
 Information   Evidence Level   Patients/Characteristics   (E:C)   (Mean:SD: N)
 Year: 1974      Inclusion: physiological      Group 2: 0/34   Group 2: 67 ± 33 hours   between groups
    Blinding: Not   jaundice   Group 2:   Group 3: 1/31
    reported      Usual nursery care + Conventional      Group 3: 72 ± 31 hours   No reason given
 Country: New      Exclusion:   phototherapy   Mortality:      for mortality
 Zealand   Randomisation:   Not reported      Group 1: 2/35   Mean rise to max TSB:
    ‘allocated in rotation’     Group 3:   Group 2: 0/34   Group 1: 80.4 ± 49.6 micromol/litre
 224
 ID:        Demographics:   Usual nursery care + phototherapy +   Group 3: 1/31
    Evidence level:2   -  Gender (M/F) : 49/51   phenobarbitone (for babies with      Group 2: 22.2 ± 29.1 micromol/litre
    Mean GA: 34.8 ± 2.7 weeks   birthweight ≥ 3kg, 8mg x 3 per day,   Group 3: 18.8 ± 29.1 micromol/litre
 For babies with birthweight < 3kg,
 Mean BW: 2155 ± 632 gms  2mg/kg x 3 per day)   Time to max TSB (hours):
 Age at entry to study
 48.1 ± 14.7 hours     Conventional Phototherapy consisted of a   Group 1: 51 ± 23 hours
 Mean TSB:   single bank of eight 30 watt fluorescent   Group 2: 14 ± 19 hours
 174 ± 40 micromol/litre   tubes behind a Perspex screen  50cm   Group 3: 13 ± 18 hours
 above the baby in a bassinet
 Light intensity = 2500 lux
 Light band = 441 nm
 Baby naked and with eyes covered
 No deliberate attempt to sequentially
 rotate the baby
 Author:   Methodology:   N:   Group 1:      Mean duration of Phototherapy   15 babies excluded
 Odell G   CCT   52   Phototherapy      Group 1: 48.1 ± 23.0 hours   retrospectively

 Year:   Blinding:   Inclusion:   Group 2:   Group 2: 37.6 ± 18.0 hours
 1983   Not reported   Hyperbilirubinaemia   Phototherapy + Agar 250mg orally every
       requiring phototherapy   8 hours during phototherapy
 Country:   Randomisation:
 USA   By patient number   Exclusion:   Phototherapy initiated at
       Not reported   239.4 micromol/litre for term babies and
 222
 ID:     Evidence level:      171 micromol/litre for preterm babies
 2 -   Demographics:
     Gender (M/F): 31/21   Phototherapy discontinued
 GA: Not reported   188.1 micromol/litre for term babies and
 BW:2767 ± 69 g   171 micromol/litre for preterm babies
 Mean age at entry to study:
 80.6 ± 28.7 hours
 Mean TSB:
 234 ± 46.8 micromol/litre
 Author:   Methodology:   N:   Group 1:      Mean decrease in TsB
 Ebbesen F   CCT   49   Phototherapy      Group 1: 87 ± 39 micromol/litre

 Year:   Blinding:   Inclusion:   Group 2:   Group 2: 85 ± 40 micromol/litre
 1977   Not reported   Hyperbilirubinaemia   Phototherapy + Agar 250mg orally at
       requiring phototherapy   feedings every three hours   Mean duration of Phototherapy



                                                                 315
   480   481   482   483   484   485   486   487   488   489   490